New miRNAs cloned from neuroblastoma

Afanasyeva, Elena A.; Hotz-Wagenblatt, Agnes; Glatting, Karl-Heinz; Westermann, Frank
January 2008
BMC Genomics;2008, Vol. 9, Special section p1
Academic Journal
Background: MicroRNAs (miRNAs) are a novel class of gene expression regulators implicated in cancer biology. Neuroblastoma (NB) is an embryonal tumour consisting of neural crest-derived undifferentiated cells and is characterised by variable clinical courses ranging from spontaneous regression to therapy-resistant progression. Recent advances identified a subset of miRNAs with putative function in NB biology. However, the full repertoire of miRNAs expressed in NBs is not available. Results: We describe miRNA profiles of 13 NB specimens and 2 NB cell lines as determined by miRNA cloning. A total of 3153 sequences were sequenced and analysed by a miRNA prediction tool (miRpredict). Our library covered 27% miRNAs known to date. 39 reads corresponding to 25 individual sequences were classified as novel miRNAs, including miRNA* species of 10 known miRNAs. Expression of 5 new miRNA* forms and 8 individual sequences was supported by Northern blotting. Most of the novel miRNA genes are not related to each other and do not share homology with the annotated sequences in the public miRNA database, but they are conserved within mammals or have close homologues in primates genomes. Conclusion: We provide evidence for 29 new miRNA and miRNA-like sequences (24 novel sequences and 5 miRNAs discovered initially in other species). Some of these newly identified sequences reside within frequently altered chromosomal regions in NB tumours and may play a role in NB biology.


Related Articles

  • Expression profiling of favorable and unfavorable neuroblastomas. Hiyama, Eiso; Hiyama, Keiko; Yamaoka, Hiroaki; Sueda, Taijiro; Reynolds, C. Patrik; Yokoyama, Takashi // Pediatric Surgery International;Jan2004, Vol. 20 Issue 1, p33 

    Neuroblastomas show remarkable biological heterogeneity, resulting in favorable or unfavorable outcomes. To survey the differences in gene expression profiles between favorable and unfavorable neuroblastomas, we analyzed ten favorable neuroblastoma samples from patients whose tumors consequently...

  • The protocadherins, PCDHB1 and PCDH7, are regulated by MeCP2 in neuronal cells and brain tissues: implication for pathogenesis of Rett syndrome.  // BMC Neuroscience;2011, Vol. 12 Issue 1, p81 

    The article focuses on a study on the identification of genomic regions that are epigenetically regulated by methyl-CpG-binding protein 2 (MeCP2) using a genome-microarray based approach, and their role in the pathogenesis of neurological features observed in Rett syndrome (RTT). The chromatin...

  • MYCN-regulated miRNA-92 inhibits secretion of the tumor suppressor DICKKOPF-3 (DKK3) in neuroblastoma. Haug, Bjørn Helge; Henriksen, Jørn R.; Buechner, Jochen; Geerts, Dirk; Tømte, Ellen; Kogner, Per; Martinsson, Tommy; Flægstad, Trond; Sveinbjørnsson, Baldur; Einvik, Christer // Carcinogenesis;Jul2011, Vol. 32 Issue 7, p1005 

    The MYCN oncogene is frequently amplified in neuroblastoma. It is one of the most consistent markers of bad prognosis for this disease. Dickkopf-3 (DKK3) is a secreted protein of the DKK family of Wnt regulators. It functions as a tumor suppressor in a range of cancers, including neuroblastoma....

  • MicroRNA-210 targets antiapoptotic Bcl-2 expression and mediates hypoxia-induced apoptosis of neuroblastoma cells. Chio, Chung-Ching; Lin, Jia-Wei; Cheng, Heien-An; Chiu, Wen-Ta; Wang, Yuan-Hung; Wang, Jhi-Joung; Hsing, Chung-Hsi; Chen, Ruei-Ming // Archives of Toxicology;Mar2013, Vol. 87 Issue 3, p459 

    MicroRNAs (miRNAs) can regulate cell survival and death by targeting apoptosis-related gene expression. miR-210 is one of the most hypoxia-sensitive miRNAs. In this study, we evaluated the roles of miR-210 in hypoxia-induced insults to neural cells. Treatment of neuro-2a cells with...

  • Logic Learning Machine creates explicit and stable rules stratifying neuroblastoma patients. Cangelosi, Davide; Blengio, Fabiola; Versteeg, Rogier; Eggert, Angelika; Garaventa, Alberto; Gambini, Claudio; Conte, Massimo; Eva, Alessandra; Muselli, Marco; Varesio, Luigi // BMC Bioinformatics;2013, Vol. 14 Issue Suppl 7, p1 

    Background: Neuroblastoma is the most common pediatric solid tumor. About fifty percent of high risk patients die despite treatment making the exploration of new and more effective strategies for improving stratification mandatory. Hypoxia is a condition of low oxygen tension occurring in poorly...

  • CD99 is upregulated in placenta and astrocytomas with a differential subcellular distribution according to the malignancy stage. Urias, Úrsula; Marie, Suely; Uno, Miyuki; Silva, Roseli; Evagelinellis, Mariá; Caballero, Otavia; Stevenson, Brian; Silva, Wilson; Simpson, Andrew; Oba-Shinjo, Sueli // Journal of Neuro-Oncology;Aug2014, Vol. 119 Issue 1, p59 

    In the present study, we searched for genes highly expressed in placenta and that could contribute to the establishment and maintenance of a malignant phenotype in different types of tumours, and in astrocytomas in particular. We employed a strategy based on the integration of in silico data...

  • Our evolving knowledge of the transcriptional landscape. Hume, David A. // Mammalian Genome;Oct2008, Vol. 19 Issue 10-12, p663 

    The development of a genome-scale approach to identification of the 5′ ends of capped mRNAs (CAGE) has given new insights into many aspects of mammalian RNApolII transcription control. They include the identification of the minimal initiator motif, the different types of proximal promoter...

  • Quantitative regulation of alternative splicing in evolution and development. Irimia, Manuel; Rukov, Jakob L.; Roy, Scott W.; Vinther, Jeppe; Garcia-Fernandez, Jordi // BioEssays;Jan2009, Vol. 31 Issue 1, p40 

    The article discusses alternative splicing (AS) in evolution and development. It categorizes the different levels of AS regulation which include genome-conservation, event-conservation and regulation-conservation. It also examines the evolution of AS regulation which directs to a high level of...

  • Tumor Transcriptome Sequencing Reveals Allelic Expression Imbalances Associated with Copy Number Alterations. Tuch, Brian B.; Laborde, Rebecca R.; Xing Xu; Jian Gu; Chung, Christina B.; Monighetti, Cinna K.; Stanley, Sarah J.; Olsen, Kerry D.; Kasperbauer, Jan L.; Moore, Eric J.; Broomer, Adam J.; Tan, Ruoying; Brzoska, Pius M.; Muller, Matthew W.; Siddiqui, Asim S.; Asmann, Yan W.; Sun, Yongming; Kuersten, Scott; Barker, Melissa A.; De La Vega, Francisco M. // PLoS ONE;2010, Vol. 5 Issue 2, p1 

    Due to growing throughput and shrinking cost, massively parallel sequencing is rapidly becoming an attractive alternative to microarrays for the genome-wide study of gene expression and copy number alterations in primary tumors. The sequencing of transcripts (RNA-Seq) should offer several...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics